Cardiovascular risk factors in overweight and obesity. Changes after a weight loss treatment;Factores de riesgo cardiovascular en el sobrepeso y la obesidad. Variaciones tras tratamiento de pérdida ponderal

Medicina Clinica

Volumn 121, Issue 13, 2003, Pages 485-491

  Bautista Castaño, Inmaculada ^a   Molina Cabrillana, Jesús ^a   Alberto Montoya Alonso, José ^a   Serra Majem, Luis ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Cardiovascular risk factors; Obesity; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0242551277     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13053138     Document Type: Article

References (48)

1. IOTF (International Obesity Task Force). Obesity prevention: the case for action. Int J Obes 2002;26:425-36.
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-y follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
3. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et. al A prospective study of obesity and risk coronary heart disease in women. N Engl J Med 1990;322:882-9.
4. Ledoux M, Lambert J, Reeder BA, Despres JP. A comparative analysis of weight to height and waist to hip circumference indices as indicators of the presence of cardiovascular disease risk factors. Canadian Heart Health Surveys Research Group. CMAJ 1997;157(Suppl 1):32-8.
5. Schulte H, Von Eckardstein A, Cullen P, Assmann G. Obesity and cardiovascular risk. Herz 2001;26:170-7
6. Zelitch-Yanovski S, Bain RP, Williamson DF. Report of National Institutes of Health-Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons. Am J Clin Nutr 1999;69:366-72.
7. Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history and lifestyle. Nutr Rev 1997;55:383-9.
8. Serra-Majem I, Aranceta J. Nutritional objectives for the Spanish population. Consensus from the Spanish Society of Community Nutrition. Public Health Nutr 2001;4(Suppl 6A):1409-13.
9. Sociedad Española para el Estudio de la Obesidad. Consenso español 1995 para la evaluación de la obesidad y para la realización de estudios epidemiológicos. Med Clin (Barc) 1996;107:782-7
10. WHO. Hypertension control. Report of a WHO Expert Committee. World Health Organization Tech Rep Ser 1996;862:1-83.
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23(Suppl 1):4-19.
12. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
13. Rabkin SW, Chen Y, Leiter L, Liu L, Reeder BA. Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group. CMAJ 1997;157(Suppl 1):26-31.
14. Magro A, Sáenz Y, Narváez I, Sáez J, Iriarte J Índice de masa corporal en Vizcaya Relación con la presión arterial. Clin Invest Arterioesclerosis 2002;14:17-20.
15. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
16. Juhaeri SJ, Stevens J, Chambless LE, Tyroler HA, Rosamond W, Nieto FJ, Schreiner P, et al. Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study. Int J Obes 2002;26:58-64
17. Hirose H, Saito I, Tsujioka M, Kawabe H, Saruta T. Effects of body weight control on changes in blood pressure: three-year follow-up study in young Japanese individuals. Hypertens Res 2000;23:421-6.
18. Ledoux M, Lambert J, Reeder BA, Despres JP. A comparative analysis of weight to height and waist to hip circumference indices as indicators of the presence of cardiovascular disease risk factors. Canadian Heart Health Surveys Research Group. CMAJ 1997;157:S32-8.
19. Whitelaw DC, O'Kane M, Wales JK, Barth JH. Risk factors for coronary heart disease in obese non-diabetic subjects. Int J Obes 2001;25:1042-6.
20. Tuomilehto J, Marti B, Kartovaara L, Korhonen HJ, Pietinen P. Body fat distribution, serum lipoproteins and blood pressure in middle-aged Finnish men and women. Rev Epidemiol Sante Publique 1990;38:507-15.
21. Plans P, Espunas J, Romero N, Barahona M, Ruigómez J, Pardell H, et al. Asociación entre hipertensión arterial, obesidad e hipercolesterolemia en una muestra de la población adulta de Cataluña. An Med Interna 1994;11:278-84.
22. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996;16:1509-15.
23. Maki KC, Kritsch K, Foley S, Soneru I, Davidson MH. Age-dependence of the relationship between adiposity and serum low density lipoprotein cholesterol in men. J Am Coll Nutr 1997;16:578-83.
24. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:676-7.
25. Yasmin, Mascie-Taylor CG. Adiposity indices and their relationship with some risk factors of coronary heart disease in middle-aged Cambridge men and women. Ann Hum Biol 2000;27:239-48.
26. Ho SC, Chen YM, Woo JLF, Leun SSF, Lam TH, Janus ED. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes 2001;25:1689-97.
27. Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach. Body mass index, abdominal adiposity and blood pressure: consistence of their association across developing and developed countries. Int J Obes 2002:26:48-57.
28. Pasanisi F, Contaldo F, De Simone G, Mancini M. Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis 2001;11:401-6.
29. Anderson JW, Konz EC. Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 2001;9(Suppl 4):326-34.
30. Solá E, Morillas C, Garzón S, Royo T, Núñez A, Bautista A. et al. Factores de riesgo cardiovascular en pacientes con obesidad y sobrepeso: influencia de la pérdida de peso. Med Clin (Barc) 2002;119:485-8.
31. McCarron DA, Reusser ME. Body weight and blood pressure regulation. Am J Clin Nutr 1996;63(Suppl 3):423-5.
32. Stamler R, Stamier J, Grimm R, Gosch FC, Elmer P, Dyer A, et al. Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial: the Hypertension Control Program. JAMA 1987;257:1484-91.
33. Stevens VJ, Corrigan S, Obarzanek E, Bernauer E, Cook NR, Hebert, P. et al. Weight, loss interventions in phase I of the Trials of Hypertension Prevention. Arch Intern Med 1993;153:849-58.
34. Schotte DE, Stunkard AJ. The effects of weight reduction on blood pressure in 301 obese patiens. Arch Intern Med 1990;150:1701-4.
35. Osterman J, Lin T, Nankin HR, Brown KA, Hornung CA. Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels. Int J Obes 1992;16:49-58.
36. Wood P, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweigt men and women. N Engl J Med 1991;325:461-6.
37. Matejkova D, Mullerova D, Rusavy Z, Muller L. Health effects of weight reduction. Sb Lek 1998;99:287-90.
38. Wing RR. Long-term effects of modest weight loss in type II diabetic patiens. Arch Intern Med 1987;147:2337-45.
39. Kasim-Karakas SE, Almario RU, Mueller WM, Peerson J. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. Am J Clin Nutr 2000;71:1439-47.
40. Turley ML, Skeaff CM, Mann JI, Cox B. The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr 1998;52:728-32.
41. Hardman A. Physical activity, obesity and blood lipids. Int J Obes 1999;23(Suppl 3):64-71.
42. Noakes M, Clifton PM. Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition. Am J Clin Nutr 2000;71:706-12.
43. Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999;42:793-801.
44. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intencional weight loss and mortality in never smoking overweight US white woman aged 40-64 years. Am J Epidemiol 1995;141:1128-41.
45. Wing RR, Shoemaker M, Marcus ND, McDermott M, Gooding W. Variables associated with weight loss and improvements in glycaemic control in type 2 diabetic patiens. Arch Intern Med 1990;147:1749-53.
46. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999;22:623-4
47. Foz M, Barbany M, Moreno B. Guías dietéticas para el tratamiento de la obesidad. En: Sociedad Española de Nutrición Comunitaria. Guías alimentarias para la población española. Madrid: IM&C, 2001: p. 401-12.
48. Sociedad Española para el Estudio de la Obesidad. Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica Med Clin (Barc) 2000;115:587-97.